Evidence map›Paper›PMID 38627185›Full record

ArticleThe International journal on drug policy2025

Introduction to the special section on polysubstance use: Emerging trends, psychosocial drivers, and treatment challenges.

Amanda Bunting, Linn Gjersing, Robert Raffa

Abstract readEditorial
In one paragraph

Article in The International journal on drug policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amanda BuntingDepartment of Population Health, New York University Grossman School of Medicine, New York, USA. Electronic address: amanda.bunting@nyulangone.org.
Linn GjersingNorwegian Institute of Public Health, Norway; Lovisenberg Diakonal University College, Department of Master and Further Education, Norway.
Robert RaffaTemple University, School of Pharmacy in Philadelphia, PA, USA; University of Arizona, College of Pharmacy in Tucson, AZ, USA.

Funding

Development of a novel polysubstance assessment tool for vulnerable subpopulationsK01DA053435 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUNTING, AMANDA M · 2021 to 2025
$909k
Polysubstance Use SymposiumR13DA057083 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUNTING, AMANDA M · 2022 to 2022
$25k
NIDA NIH HHS K01 DA053435NIDA NIH HHS R13 DA057083
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38627185
PMCPMC12121616

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.